These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31746448)

  • 1. Pharmacokinetic and Tolerability Comparison of Sustained and Immediate Release Oral Formulations of Nifedipine Tablet Formulations: A Single-Dose, Randomized, Open-Label, Two-Period, Two-Way Crossover Study in Healthy, Fasting Egyptian Male Volunteers.
    El-Masry SM; El-Khodary NM
    Drug Res (Stuttg); 2020 Feb; 70(2-03):91-96. PubMed ID: 31746448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Bioequivalence and Food Effect of Two Formulations of 30-mg Nifedipine Controlled-Release Tablets in Healthy Chinese Adults.
    Zhang H; Wang S; Wang H; Zhi T; Ren J; Wang Y; Yao Z; Zhang P; Ye N; Zhang R
    Clin Pharmacol Drug Dev; 2024 May; 13(5):499-505. PubMed ID: 38478175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation dependent pharmacokinetics--does the dosage form matter for nifedipine?
    Toal CB
    J Cardiovasc Pharmacol; 2004 Jul; 44(1):82-6. PubMed ID: 15175561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic, bioequivalence, and safety assessments of two brands of 30-mg nifedipine controlled-release formulations in Chinese healthy subjects.
    Lu H; Zhou F; Rui C; You H; Zhang W; Zhang Y; Ding J; Zhao S; Wu Q
    Int J Clin Pharmacol Ther; 2024 Oct; 62(10):486-496. PubMed ID: 39078055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic comparison of controlled-release and immediate-release oral formulations of simvastatin in healthy Korean subjects: a randomized, open-label, parallel-group, single- and multiple-dose study.
    Jang SB; Lee YJ; Lim LA; Park KM; Kwon BJ; Woo JS; Kim YI; Park MS; Kim KH; Park K
    Clin Ther; 2010 Jan; 32(1):206-16. PubMed ID: 20171425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of sustained and immediate release formulations of indapamide after single and repeated oral administration in healthy volunteers.
    Schiavi P; Jochemsen R; Guez D
    Fundam Clin Pharmacol; 2000; 14(2):139-46. PubMed ID: 10796061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration.
    Ishitsubo N; Oguro S; Shimahashi H; Kawanishi M; Adachi T; Mitsuda K; Ishibashi N
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):87-100. PubMed ID: 38064122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
    Wonnemann M; Schug B; Schmücker K; Brendel E; van Zwieten PA; Blume H
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
    Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):309-14. PubMed ID: 10890580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a New, Once-Daily, Sustained-release Pregabalin Tablet in Healthy Male Volunteers.
    Moon SJ; Jeon JY; Lim Y; An T; Jang SB; Kim S; Na WS; Lee SY; Kim MG
    Clin Ther; 2021 Aug; 43(8):1381-1391.e1. PubMed ID: 34256964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.
    Liu DJ; Collaku A
    Clin Pharmacol Drug Dev; 2018 Jan; 7(1):77-86. PubMed ID: 28815997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
    Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
    Schug BS; Brendel E; Chantraine E; Wolf D; Martin W; Schall R; Blume HH
    Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.